• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于共价有机框架的治疗诊断一体化平台用于限制 H1N1 流感病毒感染。

Covalent Organic Framework-Based Theranostic Platforms for Restricting H1N1 Influenza Virus Infection.

机构信息

Shandong Key Laboratory of Disease Control and Breeding, Institute of Animal Science and Veterinary Medicine, Shandong Academy of Agricultural Sciences, Jinan, 250100, People's Republic of China.

Key Laboratory of Shandong Microbial Engineering, College of Bioengineering, Qilu University of Technology (Shandong Academy of Sciences), Jinan, 250353, People's Republic of China.

出版信息

Int J Nanomedicine. 2024 Jul 22;19:7399-7414. doi: 10.2147/IJN.S461866. eCollection 2024.

DOI:10.2147/IJN.S461866
PMID:39071500
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11278156/
Abstract

BACKGROUND

Influenza A (H1N1) virus is a highly contagious respiratory disease that causes severe illness and death. Vaccines and antiviral drugs are limited by viral variation and drug resistance, so developing efficient integrated theranostic options appears significant in anti-influenza virus infection.

METHODS

In this study, we designed and fabricated covalent organic framework (COF) based theranostic platforms (T705@DATA-COF-Pro), which was composed of an RNA polymerase inhibitor (favipiravir, T705), the carboxyl-enriched COF (DATA-COF) nano-carrier and Cy3-labeled single DNA (ssDNA) probe.

RESULTS

The multi-porosity COF core provided an excellent micro-environment and smooth delivery for T705. The ssDNA probe coating bound to the nucleic acids of H1N1 selectively, thus controlling drug release and allowing fluorescence imaging. The combination of COF and probe triggered the synergism, promoting drug further therapeutic outcomes. With the aid of T705@DATA-COF-Pro platforms, the H1N1-infected mouse models lightly achieved diagnosis and significantly prolonged survival.

CONCLUSION

This research underscores the distinctive benefits and immense potential of COF materials in nano-preparations for virus infection, offering novel avenues for the detection and treatment of H1N1 virus infection.

摘要

背景

甲型 H1N1 流感病毒是一种高度传染性的呼吸道疾病,可导致严重疾病和死亡。疫苗和抗病毒药物受到病毒变异和耐药性的限制,因此开发有效的综合治疗选择在抗流感病毒感染方面显得尤为重要。

方法

在这项研究中,我们设计并制造了基于共价有机框架(COF)的治疗平台(T705@DATA-COF-Pro),它由 RNA 聚合酶抑制剂(法匹拉韦,T705)、富含羧基的 COF(DATA-COF)纳米载体和 Cy3 标记的单链 DNA(ssDNA)探针组成。

结果

多孔隙 COF 核为 T705 提供了极好的微环境和顺畅的输送。ssDNA 探针涂层选择性地与 H1N1 的核酸结合,从而控制药物释放并允许荧光成像。COF 和探针的结合触发了协同作用,促进了药物的进一步治疗效果。在 T705@DATA-COF-Pro 平台的辅助下,感染 H1N1 的小鼠模型得到了轻度诊断,并显著延长了存活时间。

结论

这项研究强调了 COF 材料在病毒感染纳米制剂中的独特优势和巨大潜力,为 H1N1 病毒感染的检测和治疗提供了新的途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e50a/11278156/425312c3e8a7/IJN-19-7399-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e50a/11278156/b533fac2ec47/IJN-19-7399-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e50a/11278156/cf10a8dfa1da/IJN-19-7399-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e50a/11278156/e50a0acac9fb/IJN-19-7399-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e50a/11278156/96572a78920c/IJN-19-7399-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e50a/11278156/4ff30a4d240c/IJN-19-7399-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e50a/11278156/71a02765c05c/IJN-19-7399-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e50a/11278156/425312c3e8a7/IJN-19-7399-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e50a/11278156/b533fac2ec47/IJN-19-7399-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e50a/11278156/cf10a8dfa1da/IJN-19-7399-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e50a/11278156/e50a0acac9fb/IJN-19-7399-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e50a/11278156/96572a78920c/IJN-19-7399-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e50a/11278156/4ff30a4d240c/IJN-19-7399-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e50a/11278156/71a02765c05c/IJN-19-7399-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e50a/11278156/425312c3e8a7/IJN-19-7399-g0007.jpg

相似文献

1
Covalent Organic Framework-Based Theranostic Platforms for Restricting H1N1 Influenza Virus Infection.基于共价有机框架的治疗诊断一体化平台用于限制 H1N1 流感病毒感染。
Int J Nanomedicine. 2024 Jul 22;19:7399-7414. doi: 10.2147/IJN.S461866. eCollection 2024.
2
Combination effects of peramivir and favipiravir against oseltamivir-resistant 2009 pandemic influenza A(H1N1) infection in mice.帕拉米韦与法匹拉韦联合用药对小鼠中耐奥司他韦的2009年甲型H1N1大流行性流感感染的联合效应。
PLoS One. 2014 Jul 3;9(7):e101325. doi: 10.1371/journal.pone.0101325. eCollection 2014.
3
T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro.T-705(法匹拉韦)在体外诱导甲型 H1N1 流感病毒产生致死性突变。
J Virol. 2013 Apr;87(7):3741-51. doi: 10.1128/JVI.02346-12. Epub 2013 Jan 16.
4
In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses.体外联合使用巴洛沙韦酸和其他抑制剂对季节性甲型流感病毒的作用
Viruses. 2020 Oct 8;12(10):1139. doi: 10.3390/v12101139.
5
Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis.T-705(法匹拉韦)和利巴韦林对流感病毒复制及病毒RNA合成的不同作用
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6679-6691. doi: 10.1128/AAC.01156-16. Print 2016 Nov.
6
and Characterization of Novel Neuraminidase Substitutions in Influenza A(H1N1)pdm09 Virus Identified Using Laninamivir-Mediated Selection.利用拉尼米韦介导的选择对甲型 H1N1pdm09 流感病毒中新型神经氨酸酶取代的鉴定及特征分析
J Virol. 2019 Mar 5;93(6). doi: 10.1128/JVI.01825-18. Print 2019 Mar 15.
7
Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus.奥司他韦和法匹拉韦联合治疗可延迟免疫缺陷小鼠感染大流行性 A(H1N1)流感病毒的死亡时间,但不能预防奥司他韦耐药。
Viruses. 2018 Nov 3;10(11):610. doi: 10.3390/v10110610.
8
Discovery of a Novel Specific Inhibitor Targeting Influenza A Virus Nucleoprotein with Pleiotropic Inhibitory Effects on Various Steps of the Viral Life Cycle.发现一种新型靶向流感 A 病毒核蛋白的特异性抑制剂,对病毒生命周期的各个步骤具有多效抑制作用。
J Virol. 2021 Apr 12;95(9). doi: 10.1128/JVI.01432-20.
9
Pulmonary surfactant lipids inhibit infections with the pandemic H1N1 influenza virus in several animal models.肺表面活性剂脂质可抑制几种动物模型中大流行性 H1N1 流感病毒的感染。
J Biol Chem. 2020 Feb 7;295(6):1704-1715. doi: 10.1074/jbc.RA119.012053. Epub 2019 Dec 27.
10
Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.SA-2对甲型流感病毒的体外/体内抗病毒活性及其对RNA聚合酶的抑制作用。
Antiviral Res. 2016 Mar;127:68-78. doi: 10.1016/j.antiviral.2016.01.011. Epub 2016 Jan 21.

本文引用的文献

1
Recent advances in metal-organic frameworks for stimuli-responsive drug delivery.金属有机骨架在刺激响应型药物递送上的最新进展。
Nanoscale. 2024 Feb 29;16(9):4434-4483. doi: 10.1039/d3nr05776c.
2
Red-Fluorescent Covalent Organic Framework Nanospheres for Trackable Anticancer Drug Delivery.用于可追踪抗癌药物递送的红色荧光共价有机框架纳米球
ACS Appl Mater Interfaces. 2024 Jan 10;16(1):342-352. doi: 10.1021/acsami.3c15521. Epub 2023 Dec 18.
3
Drug delivery using biocompatible covalent organic frameworks (COFs) towards a therapeutic approach.
使用生物相容性共价有机框架(COF)进行药物递送以实现治疗方法。
Chem Commun (Camb). 2023 Oct 19;59(84):12527-12547. doi: 10.1039/d3cc01829f.
4
In vitro and in vivo testing of the antiviral effect of favipiravir (T705) against the neurotropic Chandipura virus.法匹拉韦(T705)对嗜神经性钱德普尔病毒抗病毒作用的体外和体内试验
J Med Virol. 2023 Jul;95(7):e28960. doi: 10.1002/jmv.28960.
5
Bidirectionally Regulating Viral and Cellular Ferroptosis with Metastable Iron Sulfide Against Influenza Virus.双向调控不稳定铁硫化物对流感病毒的病毒和细胞铁死亡
Adv Sci (Weinh). 2023 Jun;10(17):e2206869. doi: 10.1002/advs.202206869. Epub 2023 Apr 24.
6
In Vivo Fluorescence Molecular Imaging Using Covalent Organic Nanosheets Without Labeling.无标记共价有机纳米片的体内荧光分子成像。
Adv Sci (Weinh). 2023 Jun;10(16):e2300462. doi: 10.1002/advs.202300462. Epub 2023 Apr 17.
7
Three-Dimensional Covalent Organic Framework with Topology for Drug Delivery.载药的三维共价有机框架的拓扑结构。
ACS Appl Mater Interfaces. 2022 Oct 26;14(42):48045-48051. doi: 10.1021/acsami.2c15152. Epub 2022 Oct 17.
8
Biodegradable Redox-Responsive AIEgen-Based-Covalent Organic Framework Nanocarriers for Long-Term Treatment of Myocardial Ischemia/Reperfusion Injury.基于可生物降解的氧化还原响应型聚集诱导发光的共价有机框架纳米载体用于心肌缺血/再灌注损伤的长期治疗。
Small. 2022 Nov;18(47):e2205062. doi: 10.1002/smll.202205062. Epub 2022 Oct 17.
9
Trojan Horse Delivery of Spherical Nucleic Acid Probes into the Cytoplasm for High-Fidelity Imaging of MicroRNAs.经特洛伊木马载体递送球形核酸探针进入细胞质,实现 microRNAs 的高保真成像。
Anal Chem. 2022 Aug 9;94(31):10942-10948. doi: 10.1021/acs.analchem.2c00675. Epub 2022 Jul 19.
10
Nanomaterials for virus sensing and tracking.用于病毒感测和追踪的纳米材料。
Chem Soc Rev. 2022 Jul 18;51(14):5805-5841. doi: 10.1039/d1cs01150b.